No effective pharmacological treatment for gluten-related disorders exists to date.
AMYRA is here to fix that.
The Pathologies
Celiac Disease
Overview: Celiac Disease
Celiac disease is an autoimmune disease which is caused by a GIP-induced activation of the adaptive immune system in genetically predisposed individuals. The immune reaction mainly takes place in the small intestine, where an inflammation results in acute symptoms such as chronic diarrhoea, bloating, vomiting, and abdominal pain. Furthermore, the damage wrought upon the body’s organs and tissues by this chronic inflammatory condition can lead to more malignant complications such as malnutrition, osteoporosis, and gastrointestinal cancer.
Prevalence
1% – 1.5%
Number of individuals affected globally
Non-celiac gluten sensitivity
Overview: Non-Celiac Gluten Sensitivity
Non-Celiac gluten sensitivity is a clinical syndrome that is distinct from celiac disease and wheat allergy. It is characterized by the expression of intestinal and extra intestinal symptoms (imminently) following the ingestion of gluten or other components of wheat. Common symptoms include abdominal pain, bloating, diarrhea and systemic manifestations such as ‘foggy mind’, headache, fatigue, depression and anemia.
Prevalence
~ 6%
Number of individuals affected globally
Gluten-free diet
A gluten-free diet (GFD) is the nutritional therapy implemented upon diagnosis of celiac disease or non-celiac gluten sensitivity. To date, it is the only method by which patients can avoid severe symptoms, since no effective pharmacological treatment exists. Although a GFD is beneficial, a significant proportion of patients on GFD still experience symptoms and intestinal mucosal injury. Moreover, GFD is difficult to maintain and patients often do not achieve histological remission due to continued unintentional gluten intake.
The average inadvertent consumption of gluten by celiac patients on a GFD was estimated to be between 150 and 400 milligrams per day. This is 7-20x higher than what experts deem to be non-immunogenic. Consequently, there is an urgent and unmet need for effective products capable of detoxifying GIPs to help restore quality of life and well-being in those affected by gluten-related health disorders.
Articles
A scientific perspective on how celiac disease affects the human body
During the digestion of gluten, which is a component of wheat, barley and rye, relatively long gluten fragments of proline-rich peptides are formed in the human gastrointestinal tract. These fragments are resistant to further degradation and are partially resorbed into the body...
Read MoreNon-celiac gluten sensitivity in depth
Non-celiac gluten sensitivity is a syndrome that is distinct from celiac disease and wheat allergy. Though the pathogenesis of non-celiac gluten sensitivity is poorly understood, gluten intake seems to be the major driver for the gastrointestinal, neurological and psychiatric symptoms experienced by people with non-celiac gluten sensitivity...
Read More